ANDA 76969, held by Sandoz. Metoprolol Succinate.
As of Nov 21, 2026, ANDA 76969 (Metoprolol Succinate), held by Sandoz, was first approved by FDA on Jul 31, 2006, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 31, 2006 | Original application | Approved |
| Metoprolol SuccinateEQ 25MG TARTRATE ยท tablet, extended release;oral | Metoprolol Succinate | Discontinued |
| Metoprolol SuccinateEQ 50MG TARTRATE ยท tablet, extended release;oral | Metoprolol Succinate | Discontinued |
| Metoprolol SuccinateEQ 100MG TARTRATE ยท tablet, extended release;oral | Metoprolol Succinate | Discontinued |
| Metoprolol SuccinateEQ 200MG TARTRATE ยท tablet, extended release;oral | Metoprolol Succinate | Discontinued |
| May 18, 2007 | Supplement 2Manufacturing | Approved | |
| May 18, 2007 | Supplement 3Labeling | Approved | |
| Jul 31, 2006 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. โWhat FDA's review saysโ is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters